<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">SUKNIAM, KULKAEW</style></author><author><style face="normal" font="default" size="100%">KASBI, ALI ABBASZADEH</style></author><author><style face="normal" font="default" size="100%">ASHARY, MOHAMMED ALI</style></author><author><style face="normal" font="default" size="100%">POPP, KYLE</style></author><author><style face="normal" font="default" size="100%">ATTWOOD, KRISTOPHER</style></author><author><style face="normal" font="default" size="100%">GEORGE, ANTHONY</style></author><author><style face="normal" font="default" size="100%">GABRIEL, EMMANUEL</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Disparities in Time to Treatment for Breast Cancer</style></title><secondary-title><style face="normal" font="default" size="100%">Anticancer Research</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2022-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">5813-5818</style></pages><doi><style  face="normal" font="default" size="100%">10.21873/anticanres.16088</style></doi><volume><style face="normal" font="default" size="100%">42</style></volume><issue><style face="normal" font="default" size="100%">12</style></issue><abstract><style  face="normal" font="default" size="100%">Background/Aim: This study aimed to identify the demographic/socioeconomic factors associated with disparities in time to breast cancer treatment. Patients and Methods: We conducted an analysis of breast cancer patients from the National Cancer Database, 2008-2019. Time intervals from diagnosis to surgery, radiation, and chemotherapy were compared based on age, sex, race, and socioeconomic status. Results: A total of 715,210 patients with breast cancer were included. Overall, Hispanic patients had the longest times to surgery, radiation, and chemotherapy compared to non-Hispanic patients (surgery 73.3 vs. 53.8 days, radiation 177.2 vs. 136.9 days, chemotherapy 83.0 vs. 66.5 days, all p&lt;0.01). Similarly, black patients, those who were uninsured, and those with lower income (&lt;$63,000) had the longest times to treatment. Conclusion: We identified several racial/socioeconomic disparities in time to treatment. Further investigation into the causes of these disparities is of increasing importance to address inequities in breast cancer care.</style></abstract></record></records></xml>